Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-90.36%
operating margin TTM
-40.03%
revenue TTM
6.40 Million
revenue per share TTM
1.31$
valuation ratios | |
|---|---|
| pe ratio | -0.22 |
| peg ratio | -0.01 |
| price to book ratio | 2.08 |
| price to sales ratio | 0.26 |
| enterprise value multiple | -0.42 |
| price fair value | 2.08 |
profitability ratios | |
|---|---|
| gross profit margin | 60.67% |
| operating profit margin | -40.03% |
| pretax profit margin | -98.22% |
| net profit margin | -90.36% |
| return on assets | -261.0% |
| return on equity | -1030.19% |
| return on capital employed | -236.82% |
liquidity ratio | |
|---|---|
| current ratio | 1.15 |
| quick ratio | 0.91 |
| cash ratio | 0.39 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 39.19 |
| operating cycle | 62.14 |
| days of payables outstanding | 32.81 |
| cash conversion cycle | 29.33 |
| receivables turnover | 15.91 |
| payables turnover | 11.12 |
| inventory turnover | 9.31 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.33 |
| debt equity ratio | 1.18 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.54 |
| interest coverage | -5.15 |
| cash flow to debt ratio | -3.50 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.19 |
| cash per share | 0.21 |
| operating cash flow per share | -1.19 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -3.50 |
| short term coverage ratios | -86.51 |
| capital expenditure coverage ratio | -551.50 |
Frequently Asked Questions
When was the last time NovaBay Pharmaceuticals, Inc. (AMEX:NBY) reported earnings?
NovaBay Pharmaceuticals, Inc. (NBY) published its most recent earnings results on 07-11-2024.
What is NovaBay Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. NovaBay Pharmaceuticals, Inc. (AMEX:NBY)'s trailing twelve months ROE is -1030.19%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. NovaBay Pharmaceuticals, Inc. (NBY) currently has a ROA of -261.0%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did NBY's net profit margin stand at?
NBY reported a profit margin of -90.36% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is NBY's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.15 in the most recent quarter. The quick ratio stood at 0.91, with a Debt/Eq ratio of 1.18.